Effects of Vedolizumab in Japanese Patients With Crohn’s Disease: A Prospective, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial With Exploratory Analyses

Journal of Gastroenterology - Germany
doi 10.1007/s00535-019-01647-w

Related search